About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Connect Biopharma Holdings Limited - Ordinary Shares (NQ:CNTB)

2.460 +0.070 (+2.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 446,795
Open 2.390
Bid (Size) 2.460 (1,000)
Ask (Size) 2.500 (200)
Prev. Close 2.390
Today's Range 2.350 - 2.500
52wk Range 1.020 - 3.820
Shares Outstanding 55,041,247
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026 ↗
Connect Biopharma (NASDAQ:CNTB) Chief Executive Officer Barry Quart said the company’s rademikibart program continues to show a differentiated clinical and mechanistic profile as the company awaits... 
Via MarketBeat

Performance

YTD
-2.4%
-2.4%
1 Month
+5.1%
+5.1%
3 Month
-9.6%
-9.6%
6 Month
-12.8%
-12.8%
1 Year
+132.1%
+132.1%

More News

Read More
News headline image
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
Via ACCESS Newswire
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma Announces $20.2 Million Private Placement Financing
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Which stocks have an unusual volume on Friday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
News headline image
Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
News headline image
Which stocks are moving before the opening bell on Wednesday? ↗
Via Chartmill

Frequently Asked Questions

Is Connect Biopharma Holdings Limited - Ordinary Shares publicly traded?
Yes, Connect Biopharma Holdings Limited - Ordinary Shares is publicly traded.
What exchange does Connect Biopharma Holdings Limited - Ordinary Shares trade on?
Connect Biopharma Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Connect Biopharma Holdings Limited - Ordinary Shares?
The ticker symbol for Connect Biopharma Holdings Limited - Ordinary Shares is CNTB on the Nasdaq Stock Market
What is the current price of Connect Biopharma Holdings Limited - Ordinary Shares?
The current price of Connect Biopharma Holdings Limited - Ordinary Shares is 2.460
When was Connect Biopharma Holdings Limited - Ordinary Shares last traded?
The last trade of Connect Biopharma Holdings Limited - Ordinary Shares was at 07/02/26 04:00 PM ET
What is the market capitalization of Connect Biopharma Holdings Limited - Ordinary Shares?
The market capitalization of Connect Biopharma Holdings Limited - Ordinary Shares is 135.40M
How many shares of Connect Biopharma Holdings Limited - Ordinary Shares are outstanding?
Connect Biopharma Holdings Limited - Ordinary Shares has 135M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.